Skip to main content

Table 1 Determination of cell doubling time

From: Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231

Treatment Duplication Time (hs)
Control 24.0 ± 4.3
Gli 34.6 ± 4.5 *
  1. Gli: 25 μM gliblenclamide. * p < 0.05 vs control, t test.